Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6896
Rank
NZ$1.04 B
Marketcap
NZ$52.08
Share price
0.27%
Change (1 day)
-11.64%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement